Gastroenterologist & Founder

Dr. Florence Aslinia is a gastroenterologist at the Modern Gastroenterology practice. She graduated from the faculty of medicine at the University of Tehran Medical Sciences and Health Services with the highest distinction in 1997. She served as general practitioner in underserved areas of Iran and continued her learning journey by moving to France to observe the practice of internal medicine at the Pitié-salpêtrière Hospital in Paris, France in 1999.

She pursued her internal medicine residency in the United States in Baltimore, Maryland from 2002 to 2005 and her first fellowship at Marshfield Clinic in 2006. After serving as hospitalist in Kaiser Permanente medical system for 2 years, she started her subspecialty training (fellowship) in the field of gastroenterology and hepatology at the University of Maryland Medical Center in 2008 where she also obtained a master’s degree in clinical investigation as the T32 scholar, sponsored by the NIH grant.

She joined the Johns Hopkins Hospital as faculty and gastroenterology hospitalist in 2012 where she had the opportunity to refine her skills in the field of inflammatory bowel disease under the direction of Dr. Theodore Bayless, the founder and director of the Meyerhoff Digestive Disease and Inflammatory Bowel Disease Center at Johns Hopkins Hospital.

After having a break from academia for several years while serving the community as gastroenterologist in Indiana, she joined the University of Kansas Medical center in 2017. She is the founder of the first multidisciplinary inflammatory bowel disease clinic in the state of Kansas at the University of Kansas Medical Center. She also conducted 14 research studies, mainly therapeutic agents-related clinical trials during the 5 years that she served at the University of Kansas Medical Center as faculty, clinician, and researcher. Some of those studies were on medications on their way to be approved by the FDA for management of inflammatory bowel disease. One of her most exciting industry-sponsored studies was on applying stem cells for management of complications of Crohn's disease.

In 2023, she decided to join the community practice again and continue to contribute to the field of gastroenterology, hepatology, inflammatory bowel disease, colon cancer screening and research related to those fields in the community setting.